Dyne Therapeutics

DYN · NASDAQ

$16.27+$1.04 (+6.83%)TodayMarket closed ·
Prev close $15.23

Who owns DYN

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 54.0% of DYN’s shares.

  • T. Rowe Price Investment Management, Inc.16.6%
  • Janus Henderson Investors6.4%
  • Fidelity Management & Research Company LLC6.0%
  • BlackRock Institutional Trust Company, N.A.5.7%
  • Next 6 largest institutions19.4%
  • All other shareholders46.0%
Top institutional holders of DYN
HolderShares% of shares
T. Rowe Price Investment Management, Inc.30.91M16.55%
Janus Henderson Investors12.00M6.42%
Fidelity Management & Research Company LLC11.21M6.00%
BlackRock Institutional Trust Company, N.A.10.58M5.66%
State Street Investment Management (US)7.46M3.99%
Orbis Investment Management Ltd.7.01M3.75%
Atlas Venture6.80M3.64%
Vanguard Capital Management, LLC6.31M3.38%
TCG Crossover Management, LLC4.62M2.47%
Vanguard Portfolio Management, LLC4.05M2.17%

Largest mutual fund holders

Top mutual fund holders of DYN
HolderShares% of shares
T. Rowe Price Small Cap Stock Fund7.00M3.75%
Vanguard Total Stock Market Index Fund5.26M2.82%
T. Rowe Price Small Cap Value Fund4.60M2.46%
State Street SPDR S&P Biotech ETF4.37M2.34%
iShares Russell 2000 ETF3.90M2.09%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $196.80K (5 trades) and sold $135.64M (98 trades) of DYN on the open market.

Latest DYN insider transactions
InsiderTypeSharesValue
Posner Brian SBuy2.50K$40.00K
Friedl-Naderer JohannaSale185$3.49K
Kerr DouglasSale1.29K$24.36K
Cox JohnSale5.66K$106.82K
Friedl-Naderer JohannaSale900$21.92K
Kerr DouglasSale3.75K$91.19K
Rhodes Jason PSale322.46K$8.06M
Rhodes Jason PSale478.38K$11.96M
Rhodes Jason PSale1.36M$33.99M
Friedl-Naderer JohannaSale226$5.94K

Short interest

Settled Sep 30, 2026

Shares short
25.98M
Days to cover
9.01
% of shares outstanding
13.91%
Average daily volume
2.88M
Change since last report
+11.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.